28-Year Survival following Several Metastasectomies, Going through 8th Line Systemic Therapy in a Case of mRCC

Metastatic renal cell carcinoma (mRCC) has been one of the most treatment-resistant cancers because of its unpredictable clinical course, resistance to chemo- and radiotherapy, and the limited response to immunotherapy and targeted agents. We present a case of long-term survival, that is, 28 years,...

Descripción completa

Detalles Bibliográficos
Autores principales: Magdy, A., Bretterbauer, K., Hruby, S., Kunit, T., Colleselli, D., Janetschek, G., Mitterberger, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355604/
https://www.ncbi.nlm.nih.gov/pubmed/25810943
http://dx.doi.org/10.1155/2015/523258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355604/
https://www.ncbi.nlm.nih.gov/pubmed/25810943
http://dx.doi.org/10.1155/2015/523258

Ejemplares similares